Composite anatomical-clinical-molecular prognostic model in nonsmall cell lung cancer

European Respiratory Journal

Volumn 37, Issue 1, 2011, Pages 136-142

  Lopez Encuentra A ^a   Lopez Rios F ^a   Conde, E ^a   Garcia Lujan R ^a   Suarez Gauthier A ^a   Manes N ^b   Renedo, G ^c   Duque Medina, J L ^d   Garcia Lagarto E ^e   Rami Porta, R ^f   Gonzalez Pont G ^f   Astudillo Pombo, J ^g   Mate Sanz J L ^g   Freixinet, J ^h   Romero Saavedra, T ^h   Sanchez Cespedes M ⁱ   Gomez de la Camara A ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^e Hospital Clinico Universitario   (Spain)

^f HOSPITAL MÚTUA DE TERRASSA   (Spain)

^g HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^h HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

ⁱ Structural Biology and Biocomputing Programme   (Spain)

Author keywords

Ki67cell proliferation index; Lung cancer; Mammalian target of rapamycin; Prognosis; Staging

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; BETA CATENIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KI 67 ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN P27; PROTEIN P63; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER MODEL; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLASSIFICATION ALGORITHM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCORTICOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; LARGE CELL CARCINOMA; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT CODING; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SMOKING; SURVIVAL TIME; TISSUE MICROARRAY; TUMOUR NODE AND METASTASIS STAGING SYSTEM;

AGED; ALGORITHMS; AREA UNDER CURVE; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; HUMANS; KI-67 ANTIGEN; LUNG NEOPLASMS; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; TIME FACTORS;

EID: 79251538618     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00028610     Document Type: Article

References (29)

1. Instituto Nacional de Estadística. Death according to Cause of Death 2007. www.ine.es/en/inebmenu/mnu-salud-en.htm#3 Date last accessed: February 1, 2010.
2. Duque J, López-Encuentra A, Rami-Porta R, et al. Survival of 2,991 patients with surgical lung cancer: the denominator effect in survival. Chest 2005; 28: 2274-2281.
3. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edn of the TNM Classification of malignant tumours. J Thorac Oncol 2007; 2: 706-714. (Pubitemid 47357522)
4. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002; 122: 1037-1057.
5. Zhu CQ, Shih W, Ling CH, et al. Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation. J Clin Pathol 2006; 59: 790-800.
6. Guo NL, Wan YW, Tosun K, et al. Confirmation of gene expression-based prediction of survival in non-small cell lung cancer. Clin Cancer Res 2008; 14: 8213-8220.
7. Lau SK, Boutros PC, Pintilie M, et al. Three-gene prognostic classifier for early-stage non small-cell lung cancer. J Clin Oncol 2007; 25: 5562-5569.
8. Roepman P, Jassem J, Smit EF, et al. An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer. Clin Cancer Res 2009; 15: 284-290.
9. Goldstraw P, ed. International Association for the Study of Lung Cancer. Staging Handbook in Thoracic Oncology. Orange Park, Editorial Rx-Press, 2009.
10. Lester SC. Manual of Surgical Pathology. Philadelphia, Churchill Livingstone, 2001.
11. Travis WD, Brambilla E, Müller-Hermelink HK, et al. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. World Health Organization Classification of Tumours. Lyon, IARC Press, 2004.
12. Quinlan R. C4.5: Programs for Machine Learning. San Mateo, Morgan Kaufmann Publishers, 1993.
13. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
14. Nagelkerke NJD. A note on a general definition of the coefficient of determination. Biometrika 1991; 78: 691-692.
15. Schoenfeld DA. Analysis of categorical data: logistic model. In: Mike V, Stanley KE, eds. Statistics in medical research. New York, Wiley, 1982; pp. 443-454.
16. Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest 2009; 136: 260-271.
17. Potti A, Mukherjee S, Petersen R, et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006; 355: 570-580.
18. Lee ES, Son DS, Kim SH, et al. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression. Clin Cancer Res 2008; 14: 7397-7404.
19. Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma, Shedden K, Taylor JM, et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 2008; 14: 822-827.
20. Guo L, Ma Y, Ward R, et al. Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma. Clin Cancer Res 2006; 12: 3344-3354.
21. Sun Z, Wigle DA, Yang P. Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival. J Clin Oncol 2008; 26: 877-883.
22. Zhu ZH, Sun BY, Ma Y, et al. Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer. J Clin Oncol 2009; 27: 1091-1099.
23. Chen HY, Yu SL, Chen CH, et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 2007; 356: 11-20.
24. Rami-Porta R, Ball D, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edn of the TNM classification for lung cancer. J Thorac Oncol 2007; 2: 593-602. (Pubitemid 47171780)
25. Tammemagi CM, Neslund-Dudas C, Simoff M, et al. Smoking and lung cancer survival: the role of comorbidity and treatment. Chest 2004; 125: 27-37.
26. Solomon B, Pearson RB. Class IA phosphatidylinositol 3-kinase signalling in non-small cell lung cancer. J Thorac Oncol 2009; 4: 787-791.
27. Martin B, Paesmans M, Mascaux C, et al. Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis. Br J Cancer 2004; 91: 2018-2025.
28. Conde E, Suarez-Gauthier A, García-García E, et al. Specific pattern of LKB1 and phospho-acetyl-CoA carboxylase protein immunostaining in human normal tissues and lung carcinomas. Hum Pathol 2007; 38: 1351-1360.
29. Subramanian J, Simon R. Gene expression-based prognostic signatures in lung cancer: ready for clinical use? J Natl Cancer Inst 2010; 102: 1-11.